Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Other Non Operating Income data on record, last reported at -$98000.0 in Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 262.96% year-over-year to -$98000.0; the TTM value through Dec 2025 reached -$5000.0, down 125.0%, while the annual FY2025 figure was -$5000.0, 125.0% down from the prior year.
  • Other Non Operating Income reached -$98000.0 in Q4 2025 per ORGO's latest filing, down from $18000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.9 million in Q4 2021 and bottomed at -$1.9 million in Q3 2021.
  • Average Other Non Operating Income over 5 years is $3050.0, with a median of $5500.0 recorded in 2022.
  • The widest YoY moves for Other Non Operating Income: up 26614.29% in 2021, down 4379.55% in 2021.
  • A 5-year view of Other Non Operating Income shows it stood at $1.9 million in 2021, then crashed by 99.68% to $6000.0 in 2022, then crashed by 516.67% to -$25000.0 in 2023, then dropped by 8.0% to -$27000.0 in 2024, then plummeted by 262.96% to -$98000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were -$98000.0 in Q4 2025, $18000.0 in Q3 2025, and $73000.0 in Q2 2025.